Cerner Company Profile (NASDAQ:CERN)

About Cerner (NASDAQ:CERN)

Cerner logoCerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company's segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, the Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The Company's solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Health Care Technology
  • Symbol: NASDAQ:CERN
  • CUSIP: 15678210
  • Web:
  • Market Cap: $22.57491 billion
  • Outstanding Shares: 330,429,000
Average Prices:
  • 50 Day Moving Avg: $65.55
  • 200 Day Moving Avg: $57.03
  • 52 Week Range: $47.01 - $69.28
  • Trailing P/E Ratio: 35.22
  • Foreward P/E Ratio: 26.48
  • P/E Growth: 1.85
Sales & Book Value:
  • Annual Revenue: $4.83 billion
  • Price / Sales: 4.67
  • Book Value: $12.45 per share
  • Price / Book: 5.49
  • EBIDTA: $1.35 billion
  • Net Margins: 13.74%
  • Return on Equity: 17.28%
  • Return on Assets: 12.15%
  • Debt-to-Equity Ratio: 0.13%
  • Current Ratio: 2.19%
  • Quick Ratio: 2.17%
  • Average Volume: 2.67 million shs.
  • Beta: 0.97
  • Short Ratio: 8.97

Frequently Asked Questions for Cerner (NASDAQ:CERN)

What is Cerner's stock symbol?

Cerner trades on the NASDAQ under the ticker symbol "CERN."

How will Cerner's stock buyback program work?

Cerner announced that its Board of Directors has authorized a stock buyback plan on Sunday, June 4th 2017, which permits the company to buyback $500,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to buy up to 2.3% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its stock is undervalued.

How were Cerner's earnings last quarter?

Cerner Co. (NASDAQ:CERN) announced its earnings results on Thursday, April, 27th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.53 by $0.06. The company earned $1.26 billion during the quarter, compared to analyst estimates of $1.23 billion. Cerner had a net margin of 13.74% and a return on equity of 17.28%. Cerner's quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.53 earnings per share. View Cerner's Earnings History.

When will Cerner make its next earnings announcement?

Cerner is scheduled to release their next quarterly earnings announcement on Monday, July, 31st 2017. View Earnings Estimates for Cerner.

What guidance has Cerner issued on next quarter's earnings?

Cerner issued an update on its FY17 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $2.44-2.56 for the period, compared to the Thomson Reuters consensus estimate of $2.50. The company issued revenue guidance of $5.1-5.3 billion, compared to the consensus revenue estimate of $5.18 billion.Cerner also updated its Q2 guidance to $0.60-0.62 EPS.

Where is Cerner's stock going? Where will Cerner's stock price be in 2017?

21 equities research analysts have issued 12-month price objectives for Cerner's shares. Their predictions range from $45.00 to $81.00. On average, they anticipate Cerner's share price to reach $64.45 in the next year. View Analyst Ratings for Cerner.

What are analysts saying about Cerner stock?

Here are some recent quotes from research analysts about Cerner stock:

  • 1. Cantor Fitzgerald analysts commented, "VA to adopt Millenium. On Monday, June 5, U.S. Secretary of Veterans Affairs Dr. David J. Shulkin announced his decision to replace the Veterans Health Information Systems and Technology Architecture or VistA EHR with Cerner. VA clinicians started developing an EHR system in the 1970s which has led to VistA, the primary healthcare IT system that the VA has in place today. VistA needed to be modernized to better address cyber security challenges and keep pace with the innovations in healthcare IT. Cerner indicated in an email to the investment community that it is still early in the process and will need to negotiate a contract and choose its partners. In our view, we expect the company will not recognize the contract as bookings until 4Q17, at the earliest. DoD implementation ongoing. The DoD system, known as MHS GENESIS, is based on Cerner Millennium. MHS Genesis is currently being implemented. Cerner, along with its partners, was awarded this contract in 2015. Cerner partnered with defense computing contractor Leidos and Accenture Federal Services. We note that the DoD contract is mostly a software deal for Cerner with most implementation services being provided by Cerner’s partners. The DoD win clearly put Cerner in a strong position to win the VA contract. Part of the rationale, as stated in the VA announcement, was to put the DoD and the VA on a common platform and achieve interoperability." (6/5/2017)
  • 2. According to Zacks Investment Research, "Over the past one year, Cerner has outperformed the broader industry with respect to price. However, downward estimate revision indicates looming concerns ahead of the stock. Cerner reported a mixed fourth quarter of 2016, wherein adjusted earnings beat the Zacks Consensus Estimate, while the revenues missed the same. System sales witnessed a major deterioration on a year-over-year basis, owing to a decline in technology resale. Furthermore, the HCIT market is highly competitive, which exerts considerable pressure on both pricing and margins.We believe that Cerner has growth opportunities in the revenue cycle management (RCM), Population Health and ambulatory market based on its product strength and enviable track record. Additionally, growing percentage of higher margin software in the business mix is expected to drive margins. Bookings will be key metric to watch for over the next few quarters." (4/18/2017)
  • 3. Stifel Nicolaus analysts commented, "CERN held its annual investor briefing today at the Himss conference in Orlando. The company re-iterated the financial metrics and guidance from its 4Q earnings call, which is summarized below, as well as provided updates on each of its key business initiatives. As you would expect today's briefing is more a summary of strategy and goals, which we will refer back to over the next several months. That said, there were three takeaways from today's meeting that make us on the margin more positive about the stock." (2/22/2017)

Are investors shorting Cerner?

Cerner saw a decline in short interest in the month of May. As of May 31st, there was short interest totalling 15,157,515 shares, a decline of 19.6% from the May 15th total of 18,845,404 shares. Based on an average daily volume of 2,503,476 shares, the short-interest ratio is presently 6.1 days. Approximately 5.2% of the company's stock are short sold.

Who are some of Cerner's key competitors?

Who are Cerner's key executives?

Cerner's management team includes the folowing people:

  • Neal L. Patterson, Chairman of the Board, Chief Executive Officer
  • Zane M. Burke, President
  • Clifford W. Illig, Vice Chairman of the Board of Director
  • Marc G. Naughton, Chief Financial Officer, Executive Vice President
  • Michael R. Nill, Chief Operating Officer, Executive Vice President
  • Jeffrey A. Townsend, Chief - Staff, Executive Vice President
  • Julia M. Wilson, Chief People Officer, Executive Vice President
  • Randy D. Sims, Chief Legal Officer, Senior Vice President, Secretary
  • Mitchell E. Daniels Jr., Lead Independent Director
  • Gerald E. Bisbee Jr., Ph.D., Independent Director

Who owns Cerner stock?

Cerner's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.60%), Wellington Management Group LLP (5.96%), BlackRock Inc. (5.54%), Bank of New York Mellon Corp (4.47%), State Street Corp (3.81%) and Loomis Sayles & Co. L P (2.89%). Company insiders that own Cerner stock include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, William D Zollars and Zane M Burke. View Institutional Ownership Trends for Cerner.

Who sold Cerner stock? Who is selling Cerner stock?

Cerner's stock was sold by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Manning & Napier Advisors LLC, Wellington Management Group LLP, CI Global Investments Inc., Alliancebernstein L.P., American Century Companies Inc., Morgan Stanley and TIAA CREF Investment Management LLC. Company insiders that have sold Cerner stock in the last year include Clifford W Illig, Denis A Cortese, Gerald E Bisbee, Jr, Jeffrey A Townsend, Julie M Wilson, Linda M Dillman, Marc G Naughton, Michael Nill, Michael R Battaglioli, Neal L Patterson, William D Zollars and Zane M Burke. View Insider Buying and Selling for Cerner.

Who bought Cerner stock? Who is buying Cerner stock?

Cerner's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., UBS Group AG, Bank of New York Mellon Corp, Fiduciary Management Inc. WI, Veritas Asset Management LLP, FMR LLC, Credit Suisse AG and Canada Pension Plan Investment Board. View Insider Buying and Selling for Cerner.

How do I buy Cerner stock?

Shares of Cerner can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerner's stock price today?

One share of Cerner stock can currently be purchased for approximately $68.32.

MarketBeat Community Rating for Cerner (NASDAQ CERN)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  633 (Vote Outperform)
Underperform Votes:  335 (Vote Underperform)
Total Votes:  968
MarketBeat's community ratings are surveys of what our community members think about Cerner and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cerner (NASDAQ:CERN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 13 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: $64.45 (5.66% downside)

Analysts' Ratings History for Cerner (NASDAQ:CERN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
6/6/2017J P Morgan Chase & CoReiterated RatingOverweight$65.00 -> $72.00LowView Rating Details
6/5/2017Cantor FitzgeraldReiterated RatingBuy$68.00 -> $77.00LowView Rating Details
6/2/2017Canaccord GenuityReiterated RatingBuy$66.00MediumView Rating Details
6/1/2017Jefferies Group LLCReiterated RatingBuy$74.00MediumView Rating Details
5/15/2017Bank of America CorporationUpgradeUnderperform -> Neutral$64.36 -> $66.00LowView Rating Details
5/2/2017Hilliard LyonsDowngradeBuy -> Neutral$62.00 -> $68.00MediumView Rating Details
5/1/2017Barclays PLCReiterated RatingHold$60.00LowView Rating Details
4/28/2017Leerink SwannSet Price TargetHold$65.00HighView Rating Details
2/24/2017Citigroup IncDowngradeBuy -> NeutralN/AView Rating Details
2/22/2017Stifel NicolausBoost Price TargetHold$56.00 -> $60.00N/AView Rating Details
2/10/2017CIBCReiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperform -> Market PerformN/AView Rating Details
2/10/2017Avondale PartnersDowngradeOutperform -> Market Perform$61.00 -> $45.00N/AView Rating Details
1/31/2017Deutsche Bank AGDowngradeBuy -> HoldN/AView Rating Details
12/13/2016Morgan StanleyDowngradeEqual Weight -> Underweight$62.00 -> $45.00N/AView Rating Details
12/4/2016KeyCorpReiterated RatingBuy$69.00N/AView Rating Details
11/2/2016Robert W. BairdDowngradeOutperform -> Neutral$68.00 -> $58.00N/AView Rating Details
9/8/2016Cowen and CompanyDowngradeOutperform -> Market Perform$65.00N/AView Rating Details
8/29/2016Piper Jaffray CompaniesReiterated RatingOverweight$81.00N/AView Rating Details
7/5/2016Raymond James Financial, Inc.DowngradeOutperform -> Market Perform$64.57 -> $64.57N/AView Rating Details
6/26/2016Wells Fargo & CompanyReiterated RatingBuyN/AView Rating Details
6/23/2016SunTrust Banks, Inc.UpgradeNeutral -> Buy$55.28 -> $65.00N/AView Rating Details
6/3/2016FBR & CoReiterated RatingOutperform$73.00N/AView Rating Details
5/6/2016Topeka Capital MarketsLower Price TargetBuy$65.00 -> $64.00N/AView Rating Details
2/23/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$62.00 -> $54.00N/AView Rating Details
2/17/2016Royal Bank Of CanadaLower Price TargetTop Pick$75.00 -> $70.00N/AView Rating Details
2/17/2016Evercore ISIDowngradeBuy -> Hold$68.00 -> $52.00N/AView Rating Details
(Data available from 6/25/2015 forward)


Earnings History for Cerner (NASDAQ:CERN)
Earnings by Quarter for Cerner (NASDAQ:CERN)
Earnings History by Quarter for Cerner (NASDAQ CERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017Q1 17$0.53$0.59$1.23 billion$1.26 billionViewN/AView Earnings Details
2/9/2017Q416$0.61$0.61$1.26 billion$1.26 billionViewListenView Earnings Details
11/1/2016Q316$0.56$0.55$1.24 billion$1.19 billionViewListenView Earnings Details
8/2/2016Q216$0.57$0.58$1.21 billion$1.22 billionViewListenView Earnings Details
5/5/2016Q1$0.53$0.53$1.17 billion$1.14 billionViewListenView Earnings Details
2/16/2016Q4$0.57$0.61$1.17 billion$1.18 billionViewListenView Earnings Details
11/3/2015Q315$0.54$0.54$1.17 billion$1.13 billionViewListenView Earnings Details
8/4/2015Q215$0.52$0.52$1.20 billion$1.29 billionViewListenView Earnings Details
5/7/2015Q115$0.45$0.45$1.09 billion$996.10 millionViewListenView Earnings Details
2/10/2015Q414$0.47$0.47$904.60 million$926.00 millionViewListenView Earnings Details
10/23/2014Q314$0.42$0.42$855.60 million$840.00 millionViewListenView Earnings Details
7/24/2014Q214$0.40$0.40$813.77 million$851.80 millionViewListenView Earnings Details
4/24/2014Q114$0.37$0.37$784.72 million$784.80 millionViewListenView Earnings Details
2/4/2014Q413$0.39$0.39$794.22 million$793.20 millionViewListenView Earnings Details
10/24/2013Q313$0.35$0.35$757.20 million$727.80 millionViewListenView Earnings Details
7/25/2013Q2 2013$0.34$0.34$725.71 million$707.60 millionViewListenView Earnings Details
4/25/2013Q1 2013$0.63$0.66$708.43 million$680.00 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.64$0.67$696.52 million$710.40 millionViewListenView Earnings Details
10/25/2012$0.59$0.60ViewN/AView Earnings Details
7/26/2012$0.54$0.59ViewN/AView Earnings Details
4/26/2012$0.50$0.54ViewN/AView Earnings Details
2/7/2012$0.52$0.55ViewN/AView Earnings Details
10/27/2011$0.47$0.48ViewN/AView Earnings Details
7/28/2011$0.43$0.44ViewN/AView Earnings Details
4/28/2011$0.76$0.80ViewN/AView Earnings Details
2/8/2011$0.84$0.87ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cerner (NASDAQ:CERN)
2017 EPS Consensus Estimate: $2.42
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.53$0.59$0.55
Q2 20174$0.59$0.60$0.60
Q3 20174$0.58$0.66$0.62
Q4 20174$0.62$0.69$0.65
(Data provided by Zacks Investment Research)


Dividend History for Cerner (NASDAQ:CERN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Cerner (NASDAQ:CERN)
Insider Ownership Percentage: 13.20%
Institutional Ownership Percentage: 82.77%
Insider Trades by Quarter for Cerner (NASDAQ:CERN)
Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)
Insider Trades by Quarter for Cerner (NASDAQ:CERN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/9/2017Gerald E. Bisbee, Jr.DirectorSell6,200$67.97$421,414.00View SEC Filing  
6/7/2017Julie M. WilsonEVPSell60,000$68.15$4,089,000.00View SEC Filing  
6/6/2017Marc G. NaughtonCFOSell60,000$68.63$4,117,800.00View SEC Filing  
5/22/2017Linda M. DillmanDirectorSell4,600$64.69$297,574.00View SEC Filing  
5/12/2017Neal L PattersonChairmanSell43,000$64.33$2,766,190.00View SEC Filing  
5/11/2017Clifford W IlligVice ChairmanSell234,525$64.43$15,110,445.75View SEC Filing  
5/8/2017Neal L PattersonChairmanSell180,667$64.71$11,690,961.57View SEC Filing  
5/4/2017Denis A CorteseDirectorSell1,550$64.39$99,804.50View SEC Filing  
5/4/2017Michael NillCOOSell110,000$63.91$7,030,100.00View SEC Filing  
5/1/2017Michael R BattaglioliVPSell4,000$65.55$262,200.00View SEC Filing  
3/14/2017Neal L PattersonChairmanSell20,000$54.91$1,098,200.00View SEC Filing  
2/13/2017Jeffrey A. TownsendVPSell100,000$52.31$5,231,000.00View SEC Filing  
11/7/2016William D. ZollarsDirectorSell10,000$51.50$515,000.00View SEC Filing  
9/6/2016Linda M. DillmanDirectorSell6,000$64.68$388,080.00View SEC Filing  
8/18/2016Clifford W IlligVice ChairmanSell325,705$65.10$21,203,395.50View SEC Filing  
8/10/2016Zane M. BurkePresidentSell149,480$66.73$9,974,800.40View SEC Filing  
8/9/2016Neal L PattersonChairmanSell428,638$67.14$28,778,755.32View SEC Filing  
8/8/2016Julie M. WilsonEVPSell46,923$67.27$3,156,510.21View SEC Filing  
8/8/2016Michael NillCOOSell50,000$67.16$3,358,000.00View SEC Filing  
8/8/2016Michael R BattaglioliVPSell2,000$67.34$134,680.00View SEC Filing  
6/1/2016William D ZollarsDirectorSell9,000$55.72$501,480.00View SEC Filing  
5/23/2016Linda M DillmanDirectorSell3,700$54.46$201,502.00View SEC Filing  
5/12/2016Neal L PattersonCEOSell40,000$54.24$2,169,600.00View SEC Filing  
2/19/2016Jeffrey A. TownsendVPSell100,000$51.48$5,148,000.00View SEC Filing  
2/19/2016William D. ZollarsDirectorSell11,680$51.40$600,352.00View SEC Filing  
12/14/2015Julie M. WilsonEVPSell2,821$60.52$170,726.92View SEC Filing  
12/10/2015Michael R. BattaglioliCAOSell2,000$60.06$120,120.00View SEC Filing  
6/3/2015Clifford W IlligVice ChairmanSell20,261$67.59$1,369,440.99View SEC Filing  
6/3/2015Neal L PattersonCEOSell252,340$67.37$17,000,145.80View SEC Filing  
5/26/2015Denis A CorteseDirectorSell4,000$67.52$270,080.00View SEC Filing  
5/20/2015Gerald E Bisbee JrDirectorSell6,400$68.40$437,760.00View SEC Filing  
5/19/2015Linda M DillmanDirectorSell5,900$68.63$404,917.00View SEC Filing  
5/12/2015William D ZollarsDirectorSell7,400$67.63$500,462.00View SEC Filing  
3/9/2015Michael NillCOOSell50,000$70.45$3,522,500.00View SEC Filing  
3/2/2015Zane M BurkePresidentSell50,000$71.85$3,592,500.00View SEC Filing  
2/27/2015Jeffrey A TownsendVPSell120,000$72.13$8,655,600.00View SEC Filing  
2/25/2015Neal L PattersonCEOSell54,000$73.00$3,942,000.00View SEC Filing  
2/19/2015Randy D SimsSVPSell28,874$71.11$2,053,230.14View SEC Filing  
2/18/2015Neal L PattersonCEOSell325,492$70.06$22,803,969.52View SEC Filing  
2/13/2015Marc G NaughtonCFOSell40,000$70.95$2,838,000.00View SEC Filing  
2/13/2015Michael R BattaglioliCAOSell2,000$70.92$141,840.00View SEC Filing  
2/13/2015Randy D SimsSVPSell31,126$71.06$2,211,813.56View SEC Filing  
12/1/2014Julie M WilsonEVPSell22,000$64.58$1,420,760.00View SEC Filing  
11/26/2014Clifford W IlligChairmanSell124,084$63.44$7,871,888.96View SEC Filing  
11/25/2014Clifford W IlligChairmanSell2,900$64.50$187,050.00View SEC Filing  
11/18/2014Clifford W IlligChairmanSell116,586$64.51$7,520,962.86View SEC Filing  
11/6/2014Randy D SimsSVPSell43,162$63.65$2,747,261.30View SEC Filing  
11/4/2014Randy D SimsSVPSell26,838$63.51$1,704,481.38View SEC Filing  
11/3/2014William D ZollarsDirectorSell7,900$63.30$500,070.00View SEC Filing  
10/28/2014Michael NillCOOSell50,000$62.72$3,136,000.00View SEC Filing  
9/8/2014Julie M WilsonEVPSell16,000$59.53$952,480.00View SEC Filing  
9/3/2014Michael R BattaglioliCAOSell2,000$59.21$118,420.00View SEC Filing  
8/13/2014Neal L PattersonCEOSell54,000$56.38$3,044,520.00View SEC Filing  
8/8/2014William D ZollarsDirectorSell9,200$55.20$507,840.00View SEC Filing  
5/30/2014Denis A CorteseDirectorSell4,000$54.42$217,680.00View SEC Filing  
3/11/2014Neal PattersonCEOSell231,000$60.31$13,931,610.00View SEC Filing  
2/14/2014Neal PattersonCEOSell15,000$59.90$898,500.00View SEC Filing  
2/13/2014Michael NillCOOSell50,000$57.94$2,897,000.00View SEC Filing  
2/10/2014Michael BattaglioliCAOSell2,000$56.08$112,160.00View SEC Filing  
11/8/2013Marc NaughtonCFOSell40,000$56.57$2,262,800.00View SEC Filing  
11/7/2013Neal PattersonCEOSell4,000$55.67$222,680.00View SEC Filing  
11/1/2013Zane M BurkePresidentSell39,000$55.98$2,183,220.00View SEC Filing  
10/30/2013Michael R BattaglioliCAOSell2,400$56.85$136,440.00View SEC Filing  
9/12/2013Julie WilsonEVPSell58,000$48.57$2,817,060.00View SEC Filing  
9/12/2013Michael NillCOOSell48,320$48.77$2,356,566.40View SEC Filing  
8/1/2013Marc G NaughtonCFOSell80,000$49.50$3,960,000.00View SEC Filing  
8/1/2013Neal L PattersonCEOSell1,000$49.59$49,590.00View SEC Filing  
6/12/2013Denis A CorteseDirectorSell2,000$98.00$196,000.00View SEC Filing  
5/23/2013William D ZollarsDirectorSell10,540$95.60$1,007,624.00View SEC Filing  
5/17/2013Neal L PattersonCEOSell30,000$97.05$2,911,500.00View SEC Filing  
5/15/2013Julie M WilsonEVPSell28,000$96.61$2,705,080.00View SEC Filing  
5/14/2013Neal L PattersonCEOSell15,000$95.38$1,430,700.00View SEC Filing  
5/9/2013Jeffrey A TownsendVPSell195,664$94.98$18,584,166.72View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cerner (NASDAQ:CERN)
Latest Headlines for Cerner (NASDAQ:CERN)
DateHeadline logo$1.30 Billion in Sales Expected for Cerner Corporation (CERN) This Quarter - June 25 at 9:46 AM logoInteresting CERN Put And Call Options For August 18th - June 22 at 11:17 AM logoCarolinas Healthcare System Selects Cerner’s Population Health Management Platform - June 21 at 5:21 PM logoCERN Crosses Above Average Analyst Target - June 20 at 4:51 PM logoHealthcare EDI Market Growing at a CAGR of 8.1% During 2017 to 2022 - - June 20 at 12:28 AM logoCerner Corporation (CERN) Cut to "Buy" at BidaskClub - June 15 at 6:58 PM logoHouse budgets $65M for VA to implement Cerner EHR — with a catch - June 15 at 6:01 PM logoCerner Corporation (CERN) Given Average Recommendation of "Hold" by Analysts - June 12 at 9:48 AM logoCerner Corporation (CERN) Short Interest Down 19.6% in May - June 12 at 7:18 AM logoGerald E. Bisbee, Jr. Sells 6,200 Shares of Cerner Co. (CERN) Stock - June 9 at 4:14 PM logoCerner Co. (CERN) EVP Julie M. Wilson Sells 60,000 Shares - June 8 at 7:12 PM logoCerner Co. Expected to Earn FY2018 Earnings of $2.55 Per Share (CERN) - June 8 at 12:52 PM logoJust one KC company makes Fortune 500, but are others close? - June 7 at 6:36 PM logoMarc G. Naughton Sells 60,000 Shares of Cerner Co. (CERN) Stock - June 7 at 10:21 AM logoCerner Middle East & Africa Strengthens Client Alignment with the Appointment of New Leadership Roles - June 6 at 4:25 PM logoCerner Co. (CERN) Stock Rating Reaffirmed by JPMorgan Chase & Co. - June 6 at 3:36 PM logoCerner Co. (CERN) Receives "Buy" Rating from Cantor Fitzgerald - June 5 at 5:38 PM logoVA selects Cerner to overhaul health record system - June 5 at 4:10 PM logoShare Repurchase Program Declared by Cerner (CERN) Board of Directors - June 4 at 11:08 AM logoCerner Co. (CERN) Receives "Buy" Rating from Canaccord Genuity - June 3 at 7:20 AM logoZacks: Analysts Expect Cerner Co. (CERN) Will Announce Quarterly Sales of $1.30 Billion - June 1 at 12:04 PM logoCerner looks to bolster stock price with $500M repurchase - May 30 at 4:16 PM logoCerner Co. (CERN) Expected to Announce Earnings of $0.57 Per Share - May 30 at 7:39 AM logoShort Interest in Cerner Co. (CERN) Declines By 27.4% - May 27 at 7:06 AM logoCerner, AANAC Award Nursing Assistant of the Year Scholarship - May 26 at 4:41 PM logoCerner Announces Share Repurchase Program - May 25 at 5:44 PM logoPatterson remains absent from Cerner's annual shareholder meeting - May 24 at 4:06 PM logoCerner Co. (CERN) Director Linda M. Dillman Sells 4,600 Shares - May 22 at 7:46 PM logoTruman Med, Cerner team up to help patients manage chronic disease - May 17 at 4:18 PM logoCerner to Hold 2017 Shareholder Meeting May 24 - May 17 at 11:44 AM logoScout RFP Releases Insights on Strategic Sourcing for Enterprise Success - May 16 at 4:17 PM logoTruman Medical Centers and Cerner Launch Innovation Program to Combat High-Risk Chronic Conditions - May 16 at 4:17 PM logoCerner: Behavioral health is a 'growth area' for industry - May 16 at 12:43 PM logoCerner Co. (CERN) Given Average Rating of "Hold" by Analysts - May 16 at 8:06 AM logoCerner Co. (CERN) Chairman Neal L. Patterson Sells 43,000 Shares - May 15 at 7:11 PM logoETFs with exposure to Cerner Corp. : May 15, 2017 - May 15 at 3:59 PM logoCerner Co. (CERN) Raised to Neutral at Bank of America Corp - May 15 at 10:34 AM logoCerner Co. (CERN) Vice Chairman Sells $15,110,445.75 in Stock - May 12 at 4:27 PM logoWorkforce Magazine Announces Cerner as 2017 Workforce 100 Honoree - May 11 at 4:50 PM logoInsider Selling: Cerner Co. (CERN) Chairman Sells 180,667 Shares of Stock - May 10 at 4:28 PM logoCerner Named to Forbes 2017 America’s Best Employers List - May 10 at 4:24 PM logoJeff Auxier Comments on Cerner - May 10 at 8:27 AM logo Brokerages Expect Cerner Co. (CERN) Will Announce Quarterly Sales of $1.3 Billion - May 6 at 8:46 AM logoInsider Selling: Cerner Co. (CERN) Director Sells 1,550 Shares of Stock - May 5 at 8:59 PM logoCerner Co. (CERN) COO Michael Nill Sells 110,000 Shares - May 5 at 7:54 PM logoCerner Co. (CERN) Expected to Post Earnings of $0.57 Per Share - May 4 at 1:24 PM logoSunTrust Banks Comments on Cerner Co.'s Q2 2017 Earnings (CERN) - May 4 at 9:19 AM logoMichael R. Battaglioli Sells 4,000 Shares of Cerner Co. (CERN) Stock - May 3 at 11:08 PM logoSomewhat Positive Media Coverage Likely to Impact Cerner (CERN) Stock Price - May 3 at 5:30 PM logoCerner Rises On Accelerating Growth; Earns IBD Rating Upgrade - May 3 at 4:15 PM



Cerner (CERN) Chart for Sunday, June, 25, 2017

This page was last updated on 6/25/2017 by Staff